• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » FDA nod for Hologic’s NovaSure buoys rival Conceptus | Regulatory Roundup

FDA nod for Hologic’s NovaSure buoys rival Conceptus | Regulatory Roundup

March 1, 2012 By MassDevice staff

Conceptus
Hologic

An FDA nod for Hologic (NSDQ:HOLX) will redound to the benefit of rival Conceptus (NSDQ:CPTS), making its Essure female sterilization device legally compatible with endometrial ablations systems made by Hologic, Johnson & Johnson (NYSE:JNJ) and Boston Scientific (NYSE:BSX)

The federal watchdog agency approved labeling changes for Hologic’s NovaSure endometrial ablation system, which uses bipolar radio frequency to treat menorrhagia, or excessive menstrual bleeding.

Conceptus and Hologic are waging a bitter legal war over the Essure and Hologic’s competing Adiana system, with Conceptus looking to reinforce its $19 million win with a permanent injunction to keep Hologic’s Adiana device off the U.S. market.

Sign up to get our free newsletters delivered straight to your inbox

The FDA’s NovaSure decision means the Conceptus Essure procedure “is now approved to be safe and compatible with all the major global endometrial ablation technology options that treat menorrhagia,” according to a press release.

“Our competitive advantage and leadership in the permanent birth control market has been significantly strengthened by this upgraded label,” Conceptus CEO Keith Grossman said in prepared remarks. “We will be communicating the change to the OB/GYN community, and especially to those physicians who have used the competitor’s hysteroscopic sterilization product with NovaSure.”

MassDevice.com Regulatory Roundup

The MassDevice.com Regulatory Roundup

 Peanut allergy-fighting device gets on the fast track at the FDA

Bagneux, France-based DBV Technologies said it won today that it has received fast-track designation from the FDA for its Viaskin Peanut, which is designed to treat peanut allergy via epicutaneous immunotherapy. Read more

 Varian wins 510(k) for motion-tracking transponder

Varian Medical Systems (NYSE:VAR) received 510(k) clearance from the FDA for a surface beacon transponder for its Calypso system, “as a real-time tracking device capable of monitoring motion during radiotherapy treatments for indications anywhere in the body.” Read more

 Blue Belt Technologies wins CE Mark for handheld robotic surgical cutter

Blue Belt Technologies Inc. won CE Mark approval in the European Union for its Navio PFS System, a handheld robotic cutting device. Read more

 Koning wins CE Mark for breast CT system

Koning Corp. landed CE Mark approval for its Koning Breast CT cone beam computed tomography system. Read more

Filed Under: Food & Drug Administration (FDA), News Well, Pre-Market Approval (PMA), Women's Health Tagged With: Boston Scientific, Conceptus Inc., Hologic, Johnson and Johnson, Regulatory Roundup

More recent news

  • Aurora Spine begins first procedures with Aero lumbar fusion system
  • Caranx Medical surgical robot TaviPilot AI software wins FDA clearance
  • InspireMD launches carotid stent in U.S. after FDA approval
  • Neuros Medical raises $56M Series D to support nerve stim tech
  • CorWave reports first-in-human LVAD implant

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy